Loss of palmitoylation impacts the interaction between the organic anion transporting polypeptide (OATP) 1B1 and OATP1B3
Drug Metabolism and Disposition · 2026-07 · 54 (7) · 100330
DOI: 10.1016/j.dmd.2026.100330 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Metabolism and Disposition, 2026-07. Verfasst von Cecilia E Villanueva und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, Kansas. Hauptthemen laut MEDLINE: Lipoylation, Solute Carrier Organic Anion Transporter Family Member 1B3, Liver-Specific Organic Anion Transporter 1, Organic Anion Transporters, Sodium-Independent. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
The organic anion transporting polypeptide (OATP) 1B1 and OATP1B3 are hepatic transporters that mediate the uptake of numerous therapeutics like antibiotics and statins. Various post-translational modifications, eg, phosphorylation and glycosylation, have been shown to impact OATP1B1 and OATP1B3 function and localization. S-palmitoylation (also known as S-acylation or palmitoylation) is a reversible post-translational modification that adds palmitic acid (C16:0) to cysteine residues and can influence a protein's function, localization, and protein-protein interactions. In this study, we investigated and characterized palmitoylation in OATP1B1 and OATP1B3. Using site-directed mutagenesis and acyl-resin-assisted capture assays, residue Cys24 was identified as the palmitoylation site for both these proteins. Uptake function and surface biotinylation experiments demonstrated that palmitoylation does not affect the individual function and surface expression of OATP1B1 and OATP1B3. Coexpression studies revealed a decrease in OATP1B1-OATP1B3 interactions when nonpalmitoylated OATP1B1 or nonpalmitoylated OATP1B3 are coexpressed with their wild-type counterparts, suggesting that S-palmitoylation regulates protein-protein interactions between OATP1B1 and OATP1B3. SIGNIFICANCE STATEMENT: This study identified and characterized palmitoylation of the organic anion transporting polypeptide (OATP) 1B1 and OATP1B3. Both OATP1B1 and OATP1B3 can be palmitoylated on the conserved Cys24 residue. Palmitoylation of these 2 transporters does not impact their individual function or surface expression. However, the interaction between these 2 proteins is affected when their palmitoylation state is altered.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, Kansas.
- Division of Clinical Pharmacology, Toxicology and Therapeutic Innovation, Children's Mercy Hospital, Kansas City, Missouri.
- Department of Pharmacology, Toxicology and Therapeutics, The University of Kansas Medical Center, Kansas City, Kansas. Electronic address: bhagenbuch@kumc.edu.
Förderung
- NIGMS NIH HHS
- NIH HHS
- National Institutes of Health
- National Institute of General Medical Sciences
Zitieren
APA
Villanueva, C. E., Nolte, W. M., Flores-Ascencio, P., & Hagenbuch, B. (2026). Loss of palmitoylation impacts the interaction between the organic anion transporting polypeptide (OATP) 1B1 and OATP1B3. Drug Metabolism and Disposition, 54(7), 100330. https://doi.org/10.1016/j.dmd.2026.100330
Vancouver
Villanueva CE, Nolte WM, Flores-Ascencio P, Hagenbuch B. Loss of palmitoylation impacts the interaction between the organic anion transporting polypeptide (OATP) 1B1 and OATP1B3. Drug Metabolism and Disposition. 2026;54(7):100330. doi:10.1016/j.dmd.2026.100330
BibTeX
@article{Villanueva2026,
author = {Villanueva, Cecilia E and Nolte, Whitney M and Flores-Ascencio, Priscilla and Hagenbuch, Bruno},
title = {Loss of palmitoylation impacts the interaction between the organic anion transporting polypeptide (OATP) 1B1 and OATP1B3},
journal = {Drug Metabolism and Disposition},
year = {2026},
volume = {54},
number = {7},
pages = {100330},
doi = {10.1016/j.dmd.2026.100330}
}
EUVIMED